| Patent | Date |
|---|
PIP4Ks SUPPRESS INSULIN SIGNALING AND ENHANCE IMMUNE FUNCTION THROUGH A CATALYTIC-INDEPENDENT MECHANISM
App 20220168402 - Cantley; Lewis C. ; et al. | 2022-06-02 |
Cdcp1-targeted Therapies
App 20220119545 - CANTLEY; Lewis C. ; et al. | 2022-04-21 |
Combination Therapy For Pi3k-associated Disease Or Disorder
App 20210236501 - Cantley; Lewis C. ; et al. | 2021-08-05 |
Methods for treating cancer resistant to ErbB therapeutics
Grant 11,008,620 - Janne , et al. May 18, 2 | 2021-05-18 |
Targeting Chromosomal Instability And Downstream Cytosolic Dna Signaling For Cancer Treatment
App 20210130903 - Cantley; Lewis C. ; et al. | 2021-05-06 |
Small molecule inhibitor of 3-phosphoglycerate dehydrogenase and uses thereof
Grant 10,494,365 - Cantley , et al. De | 2019-12-03 |
Small Molecule Inhibitor Of 3-phosphoglycerate Dehydrogenase And Uses Thereof
App 20190010144 - Cantley; Lewis C. ; et al. | 2019-01-10 |
Methods For Treating Cancer Resistant To Erbb Therapeutics
App 20170073760 - Janne; Pasi A. ; et al. | 2017-03-16 |
Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Grant 9,493,813 - Emerling , et al. November 15, 2 | 2016-11-15 |
Compositions and methods for treating or preventing anthracycline induced cardiotoxicity
Grant 9,119,858 - Yan , et al. September 1, 2 | 2015-09-01 |
Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1
Grant 8,883,438 - Cantley , et al. November 11, 2 | 2014-11-11 |
Methods For Treating Cancer Resistant To Erbb Therapeutics
App 20140296100 - Janne; Pasi A. ; et al. | 2014-10-02 |
Methods for treating cancer resistant to ErbB therapeutics
Grant 8,715,665 - Janne , et al. May 6, 2 | 2014-05-06 |
Modulation Of Phosphatidylinositol-5-phosphate-4-kinase Activity
App 20140080893 - Emerling; Brooke ; et al. | 2014-03-20 |
Compositions And Methods For Treating Or Preventing Anthracycline Induced Cardiotoxicity
App 20140057861 - Yan; Xinhua ; et al. | 2014-02-27 |
Methods And Compositions For Cell-proliferation-related Disorders
App 20130316385 - Cantley; Lewis C. ; et al. | 2013-11-28 |
Activators of pyruvate kinase M2 and methods of treating disease
Grant 8,552,050 - Cantley , et al. October 8, 2 | 2013-10-08 |
Methods And Compositions For The Diagnosis And Treatment Of Cellular Proliferative Disorders
App 20130203618 - Cantley; Lewis C. ; et al. | 2013-08-08 |
Methods For Treating Cancer Resistant To Erbb Therapeutics
App 20120225870 - Janne; Pasi A. ; et al. | 2012-09-06 |
Method For Treating Cancer By Increasing Amp-activated Kinase Activity
App 20120122991 - Cantley; Lewis C. ; et al. | 2012-05-17 |
Products And Processes For Modulating Peptide-peptide Binding Domain Interactions
App 20110104713 - YAFFE; Michael B. ; et al. | 2011-05-05 |
Activators Of Pyruvate Kinase M2 And Methods Of Treating Disease
App 20110046083 - Cantley; Lewis C. ; et al. | 2011-02-24 |
Methods For Identifying Diabetes And Obesity Therapeutics
App 20100311807 - Hurov; Jonathan B. ; et al. | 2010-12-09 |
Products and processes for modulating peptide-peptide binding domain interactions
App 20100030543 - Yaffe; Michael B. ; et al. | 2010-02-04 |
Tumor Suppressor Lkb1 Kinase Directly Activates Amp-Activated Kinase
App 20080194019 - Cantley; Lewis C. ; et al. | 2008-08-14 |
Products and processes for modulating peptide-peptide binding domain interactions
App 20050196808 - Yaffe, Michael B. ; et al. | 2005-09-08 |
Binding compounds and methods for identifying binding compounds
App 20030148377 - Nishikawa, Kiyotaka ; et al. | 2003-08-07 |
Methods for identifying ligands of G-Protein-Coupled receptors
App 20020192711 - Nestor, John J. ; et al. | 2002-12-19 |
Cyclic Peptide Libraries And Methods Of Use Thereof To Identify Binding Motifs
App 20020068301 - LAI, HUNG-SEN ; et al. | 2002-06-06 |
Substrate specificity of protein kinases
Grant 5,532,167 - Cantley , et al. July 2, 1 | 1996-07-02 |
| 